DEENOVA
14.3.2022 06:02:13 CET | Business Wire | Press release
Deenova today announced the unveiling of three new innovative additions to its award winning D3 product line of mechatronic solutions, in conjunction with the 26th Congress of the European Association of Hospital Pharmacists , in Vienna, Austria, March 23 to 25, 2022, at Stand 30, Hall X2.
Gaspar G. De Viedma , Vice Chairman of Deenova Board of Directors stated: “I am very excited to personally attend this launch, after a few years absence from EAHP for known personal reasons and then Covid-19. I really look forward to reconnect with the European Pharmacists thought leaders in Vienna, and witness first-hand the progress and success that Deenova has achieved in last 2 years.”
AIDE-Cut is one of three new Deenova ’s latest modular mechatronic solutions for the repackaging of oral solid medications in unit doses. It offers many possible configurations such as options mono or multi reference, typical or atypical blister format, bulk medications or for the different model of collecting the crated unit doses (in pass boxes, carnet, unit dose rolls, etc).
AIDE-Pack is Deenova ’s new solution for the repackaging of all forms of medications (Oral and non Oral) in unit dose format. Each unit dose is identified by a Datamatrix code, summarizing the main characteristics of the medication: a unique serialization number, medication code, expiration and batch.
AIDE-Pick is Deenova D3 series solution developed to fit the needs of the centralized therapy preparation in sub-acute and/or multi-site Healthcare Facilities. AIDE-Pick stores unit doses created by ACCED , AIDE-Cut , AIDE-Pack , or ALL-IN-1 unique mechatronic solutions.
Christophe Jaffuel , Deenova Chief Commercial Officer, added: “These new D3 additions of AIDE-Pick , AIDE-Cut , AIDE-Pack not only enhances Deenova long established solutions like D3 ACCED and ASTUS , but it also complements Deenova flagship solutions D1 All-In-1 Robot , D1 All-In-1 Station , D1 All-In-1 Trolley , and Orbit in an exclusive, innovative, and integrated approach to Pharmacy Automation .
Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova ’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.
Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.
Please visit www.deenova.com for additional information on its market leading solutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220313005007/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gurobi’s Decision Intelligence Summit Comes to Prague13.10.2026 09:00:00 CEST | Press release
The Gurobi Summit EMEA returns October 13–14 to showcase why optimization is the AI that drives trusted decisions. Gurobi Optimization, LLC, the leader in decision intelligence technology, today unveiled the 2026 Gurobi Decision Intelligence Summit (“Gurobi Summit”) EMEA, taking place October 13–14 in Prague. Following the U.S. version of the event, which took place September 22-23 in Las Vegas, attendees in the EMEA region will gather at the Fantova Budova for two days of innovative use case presentations, in-depth trainings, and expert-led panels. Sessions will highlight how optimization is the most suitable form of AI for delivering actionable, defensible decisions, and how generative AI can break down barriers to entry and help more users apply optimization’s full potential. This year’s presentations will include speakers from ALDI, Dutch Railways, Ryanair Labs, SAP, Skydance, and more. Several of Gurobi’s partners will also be present to showcase their solutions and expertise. In
YouHodler Italy Authorised by CONSOB as a Crypto-Asset Service Provider Under MiCA13.10.2026 09:00:00 CEST | Press release
Authorisation covers custody, exchange of crypto-assets for funds and for other crypto-assets, execution of orders and transfer services YouHodler Italy S.r.l., announces that CONSOB, after hearing the Bank of Italy, has authorised it as a crypto-asset service provider (CASP) under Regulation (EU) 2023/1114 (MiCA) and Legislative Decree 129/2024, by resolution no. 24156 of 8 October 2026. The authorisation covers five services: custody and administration of crypto-assets on behalf of clients; exchange of crypto-assets for funds; exchange of crypto-assets for other crypto-assets; execution of orders on behalf of clients; and transfer services for crypto-assets on behalf of clients. With the authorisation, YouHodler Italy serves clients in Italy as a supervised firm under MiCA's client protections: segregation of client crypto-assets, governance and security requirements, pre-contractual information and complaints handling. The company plans to extend its services to all 27 EU Member Sta
Manhattan Wins Kesko Mandate as Nordic Retail Giant Bets on Cloud-Native, AI-Driven Warehousing13.10.2026 09:00:00 CEST | Press release
The race to modernise Europe's grocery supply chains has entered a new phase, with Finnish retail group Kesko selecting ActiveWarehouse™ from leading supply chain and omnichannel commerce solutions provider Manhattan Associates Inc. (NASDAQ: MANH). The Nordic retail giant is replacing its grocery trade legacy warehouse management system with the industry’s leading, cloud-native warehouse management solution, including agentic AI capabilities delivered through ActiveAgents™ and Agent Foundry. For Finland’s second largest grocery brand, and one of the biggest in Northern Europe, the investment reflects the growing strategic importance of operational agility, as digital and physical retail become increasingly interconnected and a broader shift taking place across retail logistics more generally. The scale of Kesko’s grocery trade makes the project noteworthy in Finnish and European retail. In 2025, the division’s net sales amounted to EUR 6.5 billion, and its comparable operating profit w
Horizon3 Promotes Keith Poyser to General Manager, EMEA Following More Than 260% Regional Revenue Growth13.10.2026 09:00:00 CEST | Press release
Poyser built the EMEA team from eight to more than 110 employees and will lead the company’s next phase of expansion across the region. Horizon3 today announced the promotion of Keith Poyser to General Manager, EMEA. Previously Vice President, EMEA, Poyser will oversee the company’s next phase of growth and expansion across Europe, the Middle East and Africa. His promotion follows more than 260% regional revenue growth in the last fiscal year and the opening of Horizon3’s EMEA headquarters in Amsterdam. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261013365926/en/ Keith Poyser promoted to General Manager, EMEA following more than 260% regional revenue growth Since joining Horizon3 in September 2024, Poyser has recruited experienced talent and established a regional leadership bench, growing the EMEA team from eight to more than 110 employees. He has built a culture of trust, collaboration and accountability to support the
New Galderma Research Reveals More Than Half of Women Mistake Menopause-Related Skin Changes for Signs of Ageing13.10.2026 07:00:00 CEST | Press release
New clinical data identify optimized injectable aesthetics treatment protocol for menopause-induced skin changes 56% of women have experienced ‘The Menopausal Skin Misread’, admitting they first put menopause-related skin changes down to ageing, while fewer than a third (29%) recognized menopause as the cause1 A significant knowledge gap remains: one in two women are unaware that hormonal changes during perimenopause and menopause can affect the skin, and 82% agree that better understanding the difference between menopause-related skin changes and general ageing would help them feel more informed and in control of their skincare decisions1 New data from an investigator-initiated trial (IIT) led by Dr. Andreas Nikolis and supported by Galderma, demonstrated that a sequenced treatment approach using Restylane Skinboosters followed by Sculptra delivered significant improvements in skin hydration and remodeling across the face and décolletage in menopausal women, highlighting the value of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom